Ranibizumab is a monoclonal antibody fragment created from the same parent mouse antibody as bevacizumab.
Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
Last reviewed on RxList 12/22/2016. Lucentis (ranibizumab) Injection is a monoclonal antibody that works by slowing the growth of abnormal new blood vessels in the eye and decreasing leakage from these blood vessels used to treat the wet form of age-related macular degeneration.
VRAJ LIFE SCIENCE
Other Products in 'Pharmaceutical Injection' category